[{"address1": "Building B", "address2": "17th Floor Century Plaza Qingyang Road", "city": "Lanzhou", "country": "China", "phone": "86 93 1844 1248", "industry": "Shell Companies", "industryKey": "shell-companies", "industryDisp": "Shell Companies", "sector": "Financial Services", "sectorKey": "financial-services", "sectorDisp": "Financial Services", "longBusinessSummary": "China Dasheng Biotechnology Company, together with its subsidiaries, engages in the production, marketing, and distribution of bacteria based products used as additives for livestock feed and crop cultivation in the People's Republic of China. It provides artificial microorganisms (AM) and high-efficiency microorganism (HM) based biological bacterium blends; and biological preservatives. The company offers AM/HM bacteria based additives for crops, including Bulgaria lactobacillus, beer microzyme, and dark red spirilla used to increase the beneficial microorganism colonies in soil; inhibit the reproduction of harmful fungi and putrefactive bacteria; and to improve nutrient absorption and reduce crop and livestock diseases. It also provides AM/HM bacteria based additives for livestock feed, which softens the livestock feed and restrain the growth and reproduction of pathogenic bacteria, as well as supplies beneficial nutriments, including organic acid, vitamins, enzyme, antibiotics, mycelium protein, and other growth-enhancing substances that balance the nutrients in the feed. In addition, the company offers FGW bacterial based preservatives that preserve animal specimens for scientific research; and preserve the freshness for agricultural produce. Further, it provides bacteria based fertilizer for application on plants, such as vegetable and fruit leaves. Additionally, China Dasheng Biotechnology Company engages in residential and commercial real estate investment. The company was formerly known as Max Nutrition, Inc. and changed its name to China Dasheng Biotechnology Company in March 2008. China Dasheng Biotechnology Company was founded in 2004 and is based in Lanzhou, China.", "fullTimeEmployees": 689, "companyOfficers": [{"maxAge": 1, "name": "Mr. Jinjun  Qi", "age": 55, "title": "President & Secretary", "yearBorn": 1968, "fiscalYear": 2008, "totalPay": 28000, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Gang  Chen", "age": 60, "title": "Chairman of the Board & CEO", "yearBorn": 1963, "fiscalYear": 2008, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Hongsheng  Wang", "age": 45, "title": "Chief Financial Officer", "yearBorn": 1978, "fiscalYear": 2008, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Jingbo  Gao", "title": "Vice President of Investor Relations", "fiscalYear": 2008, "exercisedValue": 0, "unexercisedValue": 0}], "compensationAsOfEpochDate": 1230681600, "maxAge": 86400, "priceHint": 4, "previousClose": 0.029, "open": 0.01, "dayLow": 0.0144, "dayHigh": 0.029, "regularMarketPreviousClose": 0.029, "regularMarketOpen": 0.01, "regularMarketDayLow": 0.0144, "regularMarketDayHigh": 0.029, "beta": 1.373, "volume": 200, "regularMarketVolume": 200, "averageVolume": 9071, "averageVolume10days": 6894, "averageDailyVolume10Day": 6894, "bid": 0.015, "ask": 0.027, "marketCap": 1188304, "fiftyTwoWeekLow": 0.0003, "fiftyTwoWeekHigh": 0.08, "priceToSalesTrailing12Months": 0.056721468, "fiftyDayAverage": 0.018852, "twoHundredDayAverage": 0.030708, "currency": "USD", "enterpriseValue": -6047247, "profitMargins": 0.30578, "sharesOutstanding": 40976000, "impliedSharesOutstanding": 120000000, "bookValue": 0.641, "priceToBook": 0.04524181, "lastFiscalYearEnd": 1214784000, "nextFiscalYearEnd": 1246320000, "mostRecentQuarter": 1238457600, "earningsQuarterlyGrowth": 2.009, "netIncomeToCommon": 6406080, "trailingEps": -0.02, "enterpriseToRevenue": -0.289, "enterpriseToEbitda": -0.783, "52WeekChange": 0.25, "SandP52WeekChange": 0.24688339, "exchange": "PNK", "quoteType": "EQUITY", "symbol": "CDBT", "underlyingSymbol": "CDBT", "shortName": "China Dasheng Biotechnology Co.", "longName": "China Dasheng Biotechnology Company", "firstTradeDateEpochUtc": 1202913000, "timeZoneFullName": "America/New_York", "timeZoneShortName": "EDT", "uuid": "7759cfd9-65d1-33f8-a282-a789e90496ce", "messageBoardId": "finmb_40488408", "gmtOffSetMilliseconds": -14400000, "currentPrice": 0.029, "recommendationKey": "none", "totalCash": 10413273, "totalCashPerShare": 0.347, "ebitda": 7723205, "totalDebt": 18134, "quickRatio": 6.363, "currentRatio": 6.628, "totalRevenue": 20949810, "debtToEquity": 0.08, "revenuePerShare": 0.698, "returnOnAssets": 0.19871001, "returnOnEquity": 0.39153, "freeCashflow": 9731774, "operatingCashflow": 9826206, "earningsGrowth": 2.009, "revenueGrowth": 0.432, "grossMargins": 0.47847998, "ebitdaMargins": 0.36865002, "operatingMargins": 0.29537, "financialCurrency": "USD", "trailingPegRatio": null, "__fetch_time": "2024-06-06"}]